Evofem Biosciences Inc

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2019 Results - Earnings Call Transcript

The company claims a serious niche in the market of contraceptives.

Evofem To Bring A Unique Product To Growing Market

BioDelivery Sciences

Document Security Systems

Legacy Education Inc

MGM Resorts

Revolve

The GuruFocus All-in-One Screener can be used to find insider trades from the past week.

Largest Insider Trades of the Week: June 14

Aurora Cannabis

ADMA Biologics

Cleveland-Cliffs

Inseego

OrganiGram Holdings Inc.

Zynga

These seven cheap stocks under $10 all have massive upside potential according to Wall Street's top analysts.
The post 7 High-Quality Cheap Stocks to Buy With $10 appeared first on InvestorPlace.

7 High-Quality Cheap Stocks to Buy With $10

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2019 Results - Earnings Call Transcript

PDL BioPharma

Evofem's lead drug (Amphora) passed Phase 3 clinical trials. Amphora is a differentiated contraception drug. PDL will make an investment in Evofem up to 29% of equity.

Analysis Of PDL's Investment In Evofem

News for Evofem Biosciences Inc Stock (EVFM)